A Phase 3 interventional study of Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in Carcinoma, Non-Small-Cell Lung, sponsored by King Faisal Specialist Hospital & Research Center. Suspended. Per ClinicalTrials.gov, last updated 2011-03-08.
Sponsored by King Faisal Specialist Hospital & Research Center · Phase 3, Interventional, and Treatment
Randomized Phase III trial of surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in clinical early stages of non-small cell lung cancer
6,485 studies on the registry are indexed under Carcinoma, Non-Small-Cell Lung; 1,630 are open to participants now.
This study's planned enrollment of 10 is below the median of 62 across 5,211 interventional studies indexed under Carcinoma, Non-Small-Cell Lung.
Browse Carcinoma, Non-Small-Cell Lung studies →King Faisal Specialist Hospital & Research Center is the lead sponsor of 98 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Surgery alone
Radiation: Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin
Surgery + Chemo + RT
OS, MS, DFS
Time frame: overall
No study locations are listed for this record.
This study is suspended, as verified in Mar 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Carcinoma, Non-Small-Cell Lung→
King Faisal Specialist Hospital & Research Center